Who has invested in Ultromics?

Oxford Sciences Innovation are named among the investors backing Ultromics.

Ultromics Funding: $61M Raised, Series C (2024)

Ultromics funding overview

Ultromics is a Healthtech company based in Oxford, United Kingdom. Ultromics has raised $61M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Series C announced in June 2024. The round record for Ultromics runs through 2024; nothing later has been disclosed. Investors on record include Oxford Sciences Innovation.

Ultromics at a glance

Total raised: $61M
Latest round: Series C
Latest round date: June 2024
Industry: Healthtech
Headquarters: Oxford, United Kingdom
Notable investors: Oxford Sciences Innovation

Frequently asked about Ultromics funding

How much has Ultromics raised?: Ultromics has raised $61M in total disclosed funding across the rounds on record.
Who has invested in Ultromics?: Oxford Sciences Innovation are named among the investors backing Ultromics.
What was the latest Ultromics funding round?: The most recent disclosed round is a Series C, announced in June 2024.
Where is Ultromics based?: Ultromics is based in Oxford, United Kingdom.
What sector does Ultromics operate in?: Ultromics is tracked under Healthtech from Oxford, United Kingdom, with $61M in disclosed funding.
When did Ultromics last raise?: The last disclosed Ultromics round closed in June 2024 at Series C.

Totals shown for Ultromics aggregate every disclosed round on file. To see how that compares, browse the Healthtech companies in Oxford and the investors behind them below.

Ultromics Funding: $61M Raised, Series C (2024)

Ultromics funding overview

Ultromics at a glance

Frequently asked about Ultromics funding

Ultromics founders (1)

Companies related to Ultromics (39)

Browse related funding lists (3)